PREVENTION OF HEPATITIS C VIRUS RECURRENCE USING A HUMAN HEPATITS C IMMUNOGLOBULIN PREPARATION

摘要

The present invention provides for a new therapeutic capable of treating HCV infections and of avoiding HCV recurrence in liver transplant patients, using a new human HCV- immunoglobulin preparation and applying a specific dosage regimen. This treatment schedule can potentially result in a cure for HCV patients such that HCV re-infection or recurrence of disease is gravely diminished or even absent.